期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 886, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejphar.2020.173546
关键词
Magnesium supplementation; COVID-19; Supportive treatment
资金
- National Key R&D Program of China [2019YFC1711000]
- Special Funding for Emergency Research on COVID-19 in Nanjing University [020814380135]
Magnesium as an enzymatic activator is essential for various physiological functions such as cell cycle, metabolic regulation, muscle contraction, and vasomotor tone. A growing body of evidence supports that magnesium supplementation (mainly magnesium sulfate and magnesium oxide) prevents or treats various types of disorders or diseases related to respiratory system, reproductive system, nervous system, digestive system, and cardiovascular system as well as kidney injury, diabetes and cancer. The ongoing pandemic coronavirus disease 19 (COVID-19) characterized by respiratory tract symptoms with different degrees of important organ and tissue damages has attracted global attention. Particularly, effective drugs are still lacking in the COVID-19 therapy. In this review, we find and summarize the effectiveness of magnesium supplementation on the disorders or diseases, and provide a reference to the possibility of magnesium supplementation for supportive treatment in patients with COVID-19.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据